✦ LIBER ✦

Invasive aspergillosis in a patient with aplastic anemia receiving amphotericin B

✍ Scribed by Antoine, Grogory A. ;Gates, Robert H. ;Park, Alfred O.

Publisher: Wiley (John Wiley & Sons)
Year: 1988
Weight: 579 KB
Volume: 10
Category: Article
ISSN: 0148-6403
DOI: 10.1002/hed.2890100309

No coin nor oath required. For personal study only.

✦ Synopsis

Invasive mycotic infections are becoming more commonplace in immune-compromised hosts. Aspergillus species is the most commonly encountered fungal genus in our environment causing paranasal sinus fungal infection. Aspergillus paranasal sinus infections in the healthy host are readily treated and controlled. In the immune-compromised host this common organism can rapidly become fatal even if recognized and treated appropriately. We present a case history of a patient who died from her disease despite radical surgery and antifungicidal therapy. Recent methods for early diagnosis will be reviewed. Only one other case has been reported in the literature of a patient developing fulminant aspergillosis sinusitis while receiving amphotericin B.

📜 SIMILAR VOLUMES

Invasive bronchopulmonary aspergillosis

Invasive bronchopulmonary aspergillosis leading to rapidly progessive respiratory failure in a patient with severe aplastic anemia

✍ Höfeler, H. ;Popescu, O. ;Kath, R. ;Höffken, K. ;Schmidt, C. G. 📂 Article 📅 1987 🏛 Springer-Verlag 🌐 English ⚖ 464 KB

Amphotericin B lipid complex versus lipo

Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy

✍ Ray Y. Hachem; Maha R. Boktour; Hend A. Hanna; Rola N. Husni; Harrys A. Torres; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

## Abstract ## BACKGROUND. Invasive aspergillosis (IA) is a major cause of morbidity and mortality in patients with hematologic malignancy (HM). There are 2 lipid formulations of amphotericin B (AMB) currently in widespread use: AMB lipid complex (ABLC) and liposomal AMB (L‐AMB). There are limited

Oral itraconazole plus nasal amphoterici

Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with hematological malignancies

✍ G. Todeschini; C. Murari; R. Bonesi; G. Pizzolo; G. Amaddi; A. Ambrosetti; S. Ce 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 568 KB

Aerosol amphotericin B inhalations for p

Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients

✍ G. F. Behre; S. Schwartz; K. Lenz; W. -D. Ludwig; H. Wandt; E. Schilling; V. Hei 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 588 KB

Human parvovirus B19 in patients with ap

Human parvovirus B19 in patients with aplastic anemia

✍ Baijayantimala Mishra; Pankaj Malhotra; Radha Kanta Ratho; Mini P. Singh; Subhas 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB 👁 2 views

Liposomal amphotericin B in combination

Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies : A randomized pilot study (Combistrat trial)

✍ Denis Caillot; Anne Thiébaut; Raoul Herbrecht; Stéphane de Botton; Arnaud Pigneu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

## Abstract ## BACKGROUND. Invasive aspergillosis (IA) has a poor prognosis in immunocompromised patients. Combinations of drugs that act on different targets are expected to improve the clinical efficacy of separate compounds. ## METHODS. Patients with proven or probable IA were randomized in a